Nouvelles de la Bourse
Dernières actualités financières · Mis à jour Mai 24, 2026
Truist réduit son objectif de cours sur Fifth Third Bancorp (FITB), maintient une note d'achat.
Truist Lowers PT on Fifth Third Bancorp (FITB), Keeps a Buy Rating
The panel's net takeaway is that Truist's price target cut for FITB reflects concerns about slowing loan growth, net interest …
JD.com (JD) et BYD entrent dans un partenariat stratégique
JD.com (JD) and BYD Enters a Strategic Partnership
The panel views JD.com's partnership with BYD as a strategic move that leverages JD's logistics footprint and BYD's EV and …
Morgan Stanley Maintient une Recommandation à l'Achat sur Block (XYZ)
Morgan Stanley Maintains a Buy on Block (XYZ)
The panel is largely bearish on Block (SQ), citing risks such as potential loss of institutional memory from significant headcount …
Le plafonnement des médicaments à 2 000 $ permet aux retraités de la Medicare d’économiser plus de 1 500 $ par an en ce moment
The $2,000 Drug Cap Is Saving Medicare Retirees Over $1,500 a Year Right Now
The $2,000 Part D cap provides significant relief for high-cost drug users but may have unintended consequences. While it increases …
Huntington Bancshares (HBAN) présente lors de la conférence RBC 2026, voici ce que vous devriez savoir.
Huntington Bancshares (HBAN) Presents at RBC 2026 Conference, Here’s What You Should Know
The panel's net takeaway is that HBAN's guidance is solid but faces significant risks, particularly around deposit betas, merger accounting, …
Stellantis (STLA) Envisage des Partenariats Avec des Constructeurs Automobiles Chinois
Stellantis (STLA) Considering Partnerships With Chinese Automakers
The panel consensus is that Stellantis' exploration of partnerships with Chinese OEMs is a desperate move to address its European …
Actions des actions américaines bien au-dessus des plus bas, mais clôture tout de même en baisse
U.S. Stocks Climb Well Off Worst Levels But Still Close Lower
The panelists agree that the market's resilience despite geopolitical tensions is deceptive, with energy infrastructure damage posing a significant risk …
Comment Évalue-t-on la Performance de l'Action Baxter Par Rapport aux Autres Actions de Dispositifs MédicauxM ?
How Is Baxter's Stock Performance Compared to Other Medical Devices Stocks?
The panel consensus is bearish on Baxter (BAX), citing persistent margin pressure, operational struggles, and a high debt load. While …
G2 Investment Partners initie une nouvelle position chez Xometry
G2 Investment Partners Initiates a New Position in Xometry
Despite impressive revenue growth, XMTR's significant net losses and unclear path to profitability remain a concern, with varying opinions on …
SBSW Atteint un Passage Notable en Dessous de sa Moyenne Mobile Critique
SBSW Makes Notable Cross Below Critical Moving Average
The panel consensus is bearish on Sibanye Stillwater (SBSW) due to its sensitivity to PGM prices, South African operational risks, …
BioMarin Pharmaceutical (BMRN) Publie les Résultats Positifs des Essais Cliniques en Cours de VOXZOGO
BioMarin Pharmaceutical (BMRN) Reports Positive Results From Ongoing Trials of VOXZOGO
The panel discusses BioMarin's VOXZOGO (vosoritide) data, with mixed views on its commercial potential. Bulls highlight label expansion to infants …
La nouvelle défense aérienne de la Grèce stimulera-t-elle l'action Lockheed Martin>?
Will Greece's New Air Defense Plan Boost Lockheed Martin's Stock?
The panel generally agrees that the $36B Greece deal for Lockheed Martin (LMT) is geopolitically important but economically modest, with …